Vaccine could virtually eliminate cervical cancer: study

  • 📰 YahooSG
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 71%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Vaccine could virtually eliminate cervical cancer: study.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Vaccine could virtually eliminate cervical cancer: StudyPARIS (AFP) - The rapid scale-up of the human papillomavirus (HPV) vaccine could virtually eliminate cervical cancer in a handful of rich countries within three decades, and in most other nations by century's end, researchers said on Wednesday (Feb 20).. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Vaccine could virtually eliminate cervical cancer: StudyPARIS (AFP) - The rapid scale-up of the human papillomavirus (HPV) vaccine could virtually eliminate cervical cancer in a handful of rich countries within three decades, and in most other nations by century's end, researchers said on Wednesday (Feb 20).. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Merck's Keytruda fails late-stage study in liver cancer patientsMerck & Co Inc said on Tuesday its cancer drug Keytruda failed the main goals of a late-stage trial and did not extend life of patients with a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Merck to further study Keytruda in prostate cancer after early successMerck & Co Inc said on Thursday it was launching three late-stage studies for its cancer immunotherapy Keytruda as a combination treatment for ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Merck, Pfizer drug combo extends kidney cancer survival: studyA combination of Merck & Co's immunotherapy Keytruda and Pfizer Inc's Inlyta helped patients with advanced kidney cancer live longer than those ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Lack of sleep could damage DNA and affect repair ability, possibly raising cancer risk: StudyOk
Source: TODAYonline - 🏆 1. / 99 Read more »

Liver cancer top cause of cancer death among men in their 40s and 50sThe statistics about hepatocellular carcinoma (HCC), the most common type of primary liver cancer, are troubling. Eighty per cent of all the cases in the world occur in Asia, and it has come to be known as an 'Asian disease'. HCC is the third most common cause of...
Source: thenewpaper - 🏆 7. / 63 Read more »

'Killer' cells raise hope of universal flu vaccineScientists said Monday they had discovered immune cells that can fight all known flu viruses in what was hailed as an 'extraordinary breakthrough' that could lead to a universal, one-shot vaccine against the killer disease. Researchers in Australia said that 'killer T cells' -- found
Source: YahooSG - 🏆 3. / 71 Read more »